Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition(s):Leukemia; Relapsed; Myeloid; AcuteLast Updated:January 24, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Leukemia; Relapsed; Myeloid; AcuteLast Updated:January 24, 2024Recruiting
Condition(s):Advanced Malignant Solid TumorLast Updated:February 15, 2024Terminated
Condition(s):COVID-19Last Updated:March 18, 2022Terminated
Condition(s):Covid19Last Updated:September 8, 2021Completed
Condition(s):Advanced Solid TumorLast Updated:December 22, 2022Completed
Condition(s):EGFR-mutated NSCLC (Disorder)Last Updated:March 23, 2023Terminated
Condition(s):Multiple Myeloma in RelapseLast Updated:August 25, 2021Completed
Condition(s):NeoplasmsLast Updated:January 10, 2022Completed
Condition(s):NeoplasmsLast Updated:August 7, 2019Completed
Condition(s):COVID-19Last Updated:January 18, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.